Potential Covid-19 Treatment Is Ready for Prime Time: https://t.co/L1KzivERyV

Small-cap Algernon Pharmaceuticals is about to begin a Phase 2b/3 trial for Ifenprodil, a repurposed drug with a known safety record.

$AGN.CA $AGNPF #covid19 #healthcare #stocks @AlgernonPharma https://t.co/EySr5XvKLG